3 completed, 2 unknown, 1 recruiting. 6 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 3, Unknown 2, Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow TP: new trials by email Literature Review of TP trials Research Report on TP
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma Paclitaxel and Cisplatin, Cadonilimab, Radiotherapy - Endometrial Neoplasms, Neoplasm Recurrence, Local | Phase 2 | Recruiting | Shandong Cancer Hospital and Institute | 30 | 2024-06-13 | 2026-04-24 |
| Combination of Toripalimab and Chemoradiotherapy in Esophageal Cancer Toripalimab, Paclitaxel/Cisplatin, Intensity-modulated radiotherapy - Unresectable Esophageal Cancer | Phase 2 | Completed | Mian XI | 42 | 2019-06-25 | 2022-08-23 |
| Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer Toripalimab, Paclitaxel/cisplatin, Intensity-modulated radiotherapy - Esophageal Squamous Cell Carcinoma by AJCC V8 Stage, Resectable Esophageal Cancer | Phase 2 | Unknown | Jianhua Fu | 44 | 2019-06-25 | 2019-12-26 |
| Autologous Tumor Tissue Antigen-sensitized DC-CIK Cells Combined With Chemotherapy for Esophageal Cancer Paclitaxel, DC-CIK, Cisplatin - Esophageal Neoplasms, Neoplasms | Phase 2 | Unknown | Shenzhen Hornetcorn Bio-technology Company, LTD | 60 | 2015-12-01 | 2016-05-24 |
| GP VS TP in the Treatment of Advanced Nasopharyngeal Carcinoma in Northwest China gemcitabine and cisplatin, docetaxel and cisplatin - Nasopharyngeal Squamous Cell Carcinoma, Toxicity Due to Radiotherapy | Phase 2 | Completed | Air Force Military Medical University, China | 60 | 2012-05-01 | 2013-10-30 |
| Docetaxel+Carboplatin vs Epirubicin+Cyclophosphamide Followed by Docetaxel as Adjuvant Treatment in Triple-negative Breast Cancer EC-T, TP - Breast Cancer | Phase 2 / Phase 3 | Completed | Chinese Academy of Medical Sciences | 320 | 2009-06-01 | 2021-02-09 |
Esophageal Squamous Cell Carcinoma (2) · Neoplasms (2) · Breast Neoplasms (1) · Digestive System Neoplasms (1) · Endometrial Neoplasms (1) · Esophageal Neoplasms (1) · Neoplasm Metastasis (1) · Neoplasm Recurrence, Local (1) · Pathologic Complete Response (1)
Air Force Military Medical University, China (1) · Chinese Academy of Medical Sciences (1) · Jianhua Fu (1) · Mian XI (1) · Shandong Cancer Hospital and Institute (1) · Shenzhen Hornetcorn Bio-technology Company, LTD (1)
China (6)
Jianhua Fu, MD (1) · Mei Shi, MD (1) · Peng Xie (1) · Peng Yuan, MD (1) · Zhiyuan Wang, Professor (1)
PMID 28317872, PMID 30642373, PMID 34648118, PMID 36861447, PMID 36990609, PMID 37560259, PMID 39235488, PMID 39281099